NL6502034A - - Google Patents

Info

Publication number
NL6502034A
NL6502034A NL6502034A NL6502034A NL6502034A NL 6502034 A NL6502034 A NL 6502034A NL 6502034 A NL6502034 A NL 6502034A NL 6502034 A NL6502034 A NL 6502034A NL 6502034 A NL6502034 A NL 6502034A
Authority
NL
Netherlands
Application number
NL6502034A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6502034A publication Critical patent/NL6502034A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
NL6502034A 1964-02-21 1965-02-18 NL6502034A (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB731364A GB1025156A (en) 1964-02-21 1964-02-21 A 19-nor-4-androsten-17ª‰-ol-3-one ester

Publications (1)

Publication Number Publication Date
NL6502034A true NL6502034A (zh) 1965-08-23

Family

ID=9830744

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6502034A NL6502034A (zh) 1964-02-21 1965-02-18

Country Status (4)

Country Link
BE (1) BE659440A (zh)
DE (1) DE1253267B (zh)
GB (1) GB1025156A (zh)
NL (1) NL6502034A (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4308265A (en) * 1979-10-05 1981-12-29 United States Of America 7α-Methylnorethindrone enanthate and its use in long term suppression of fertility in female mammals

Also Published As

Publication number Publication date
DE1253267C2 (zh) 1968-05-09
GB1025156A (en) 1966-04-06
BE659440A (zh) 1965-05-28
DE1253267B (de) 1967-11-02

Similar Documents

Publication Publication Date Title
AU442366B2 (zh)
BE642470A (zh)
BE642367A (zh)
BE432268A (zh)
BE47396A (zh)
BE483969A (zh)
BE507097A (zh)
BE518974A (zh)
BE554195A (zh)
BE564626A (zh)
BE584699A (zh)
BE603534A (zh)
BE613833A (zh)
BE621510A (zh)
BE622126A (zh)
BE623398A (zh)
BE626083A (zh)
BE626684A (zh)
BE627057A (zh)
BE627390A (zh)
BE627931A (zh)
BE628611A (zh)
BE629793A (zh)
BE632875A (zh)
BE636791A (zh)